TuisEWL • ETR
add
Edwards Lifesciences Corp
Vorige sluiting
€69,07
Dagwisseling
€68,99 - €69,66
Jaarwisseling
€54,00 - €88,64
Markkapitalisasie
41,45 mjd USD
Gemiddelde volume
552,00
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NYSE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 1,35 mjd | 8,93% |
Bedryfskoste | 697,20 m | 11,61% |
Netto inkomste | 3,07 mjd | 697,82% |
Netto winsgrens | 226,73 | 632,33% |
Wins per aandeel | 0,67 | 13,56% |
EBITDA | 428,80 m | 5,88% |
Effektiewe belastingkoers | 10,10% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 4,45 mjd | 138,54% |
Totale bates | 12,97 mjd | 38,42% |
Totale aanspreeklikheid | 3,36 mjd | 27,09% |
Totale ekwiteit | 9,61 mjd | — |
Uitstaande aandele | 589,80 m | — |
Prys om te bespreek | 4,27 | — |
Opbrengs op bates | 8,55% | — |
Opbrengs op kapitaal | 10,65% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 3,07 mjd | 697,82% |
Kontant van bedrywe | 351,80 m | -14,51% |
Kontant van beleggings | 2,70 mjd | 2 935,62% |
Kontant van finansiering | -976,70 m | -581,58% |
Netto kontantverandering | 2,03 mjd | 452,76% |
Beskikbare kontantvloei | 1,23 mjd | 378,57% |
Meer oor
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility due to be completed in 2021 in Limerick, Ireland. Wikipedia
Gestig
1958
Hoofkwartier
Webwerf
Werknemers
19 800
